BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37657359)

  • 21.
    Otaguiri KK; Dos Santos DF; Slavov SN; Depieri LV; Palma PVB; Meirelles FV; Covas DT; da Silveira JC; Kashima S
    AIDS Res Hum Retroviruses; 2018 Dec; 34(12):1075-1082. PubMed ID: 30229663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
    Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
    J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HTLV-1-host interactions on the development of adult T cell leukemia/lymphoma: virus and host gene expressions.
    Tarokhian H; Rahimi H; Mosavat A; Shirdel A; Rafatpanah H; Akbarin MM; Bari A; Ramezani S; Rezaee SA
    BMC Cancer; 2018 Dec; 18(1):1287. PubMed ID: 30577817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered expression of degranulation-related genes in CD8+ T cells in human T lymphotropic virus type I infection.
    Malta TM; Silva IT; Pinheiro DG; Santos AR; Pinto MT; Panepucci RA; Takayanagui OM; Tanaka Y; Covas DT; Kashima S
    AIDS Res Hum Retroviruses; 2013 May; 29(5):826-36. PubMed ID: 23301858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a systems virology study.
    Zarei Ghobadi M; Emamzadeh R; Teymoori-Rad M; Mozhgani SH
    Virol J; 2021 Aug; 18(1):175. PubMed ID: 34446027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Matsuzaki T; Satou Y; Yasunaga J; Saito K; Arimura K; Matsuoka M; Ohara Y
    Retrovirology; 2009 Feb; 6():19. PubMed ID: 19228429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis.
    Tendler CL; Greenberg SJ; Burton JD; Danielpour D; Kim SJ; Blattner WA; Manns A; Waldmann TA
    J Cell Biochem; 1991 Aug; 46(4):302-11. PubMed ID: 1757474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
    Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
    J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.
    Guerreiro JB; Santos SB; Morgan DJ; Porto AF; Muniz AL; Ho JL; Teixeira AL; Teixeira MM; Carvalho EM
    Clin Exp Immunol; 2006 Aug; 145(2):296-301. PubMed ID: 16879249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic strategies in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Nakamura T; Nishiura Y; Eguchi K
    Cent Nerv Syst Agents Med Chem; 2009 Jun; 9(2):137-49. PubMed ID: 20021347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurological Manifestations in Human T-Cell Lymphotropic Virus Type 1 (HTLV-1)-Infected Individuals Without HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: A Longitudinal Cohort Study.
    Tanajura D; Castro N; Oliveira P; Neto A; Muniz A; Carvalho NB; Orge G; Santos S; Glesby MJ; Carvalho EM
    Clin Infect Dis; 2015 Jul; 61(1):49-56. PubMed ID: 25820277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An insight to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) pathogenesis; evidence from high-throughput data integration and meta-analysis.
    Mozhgani SH; Piran M; Zarei-Ghobadi M; Jafari M; Jazayeri SM; Mokhtari-Azad T; Teymoori-Rad M; Valizadeh N; Farajifard H; Mirzaie M; Khamseh A; Rafatpanah H; Rezaee SA; Norouzi M
    Retrovirology; 2019 Dec; 16(1):46. PubMed ID: 31888669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of T Regulatory Lymphocytes Transcription Factors in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Patients.
    Ghezeldasht SA; Sadeghian H; Azarpazhooh MR; Shamsian SAA; Rafatpanah H; Mahmoodi M; Rezaee SA
    Appl Biochem Biotechnol; 2017 Aug; 182(4):1403-1414. PubMed ID: 28101786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A significant association between CXCL10 -1447 A > G and IL18 -607 C > A gene polymorphism with human T-cell lymphotropic virus type 1 associated myelopathy/tropical spastic paraparesis (HAM-TSP), a case-control report from city of Mashhad, Iran.
    Rafatpanah H; Poursina Z; Boostani R; Marzouni HZ; Atabaki M; Hosseini RF; Tavakkol-Afshari J; Mohammadi M
    J Neurovirol; 2021 Apr; 27(2):249-259. PubMed ID: 33651323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased human T lymphotropic virus type-1 (HTLV-1) proviral DNA in peripheral blood mononuclear cells and bronchoalveolar lavage cells from Japanese patients with HTLV-1-associated myelopathy.
    Mita S; Sugimoto M; Nakamura M; Murakami T; Tokunaga M; Uyama E; Araki S
    Am J Trop Med Hyg; 1993 Feb; 48(2):170-7. PubMed ID: 8447519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coevolution of HTLV-1-HBZ, Tax, and proviral load with host IRF-1 and CCNA-2 in HAM/TSP patients.
    Saffari M; Rahimzada M; Mirhosseini A; Ghezaldasht SA; Valizadeh N; Moshfegh M; Moradi MT; Rezaee SA
    Infect Genet Evol; 2022 Sep; 103():105337. PubMed ID: 35835355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
    Romanelli LC; Caramelli P; Martins ML; Gonçalves DU; Proietti FA; Ribas JG; Araújo MG; Carneiro-Proietti AB
    AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1199-202. PubMed ID: 23617363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Putative role of HLA polymorphism among a Brazilian HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) population.
    Schor D; Porto LC; Roma EH; Castro-Alves J; Villela AP; Araújo AQC; Glória Bonecini-Almeida M
    Sci Rep; 2023 May; 13(1):7659. PubMed ID: 37169817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: influence of clinical status, sex, and familial relatedness.
    Adaui V; Verdonck K; Best I; González E; Tipismana M; Arévalo J; Vanham G; Campos M; Zimic M; Gotuzzo E
    J Neurovirol; 2006 Dec; 12(6):456-65. PubMed ID: 17162661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) versus adult T-cell leukemia/lymphoma (ATLL).
    Zarei-Ghobadi M; Sheikhi M; Teymoori-Rad M; Yaslianifard S; Norouzi M; Yaslianifard S; Faraji R; Farahmand M; Bayat S; Jafari M; Mozhgani SH
    BMC Res Notes; 2021 Mar; 14(1):109. PubMed ID: 33757561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.